nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.108	0.282	CbGbCtD
Pimecrolimus—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0729	0.19	CbGbCtD
Pimecrolimus—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0695	0.182	CbGbCtD
Pimecrolimus—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.062	0.162	CbGbCtD
Pimecrolimus—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0364	0.0949	CbGbCtD
Pimecrolimus—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0343	0.0897	CbGbCtD
Pimecrolimus—MTOR—leg—chronic obstructive pulmonary disease	0.0307	0.349	CbGeAlD
Pimecrolimus—MTOR—respiratory system—chronic obstructive pulmonary disease	0.00764	0.0867	CbGeAlD
Pimecrolimus—FKBP1A—respiratory system—chronic obstructive pulmonary disease	0.00687	0.0779	CbGeAlD
Pimecrolimus—MTOR—connective tissue—chronic obstructive pulmonary disease	0.00672	0.0763	CbGeAlD
Pimecrolimus—MTOR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00615	0.0698	CbGeAlD
Pimecrolimus—FKBP1A—connective tissue—chronic obstructive pulmonary disease	0.00605	0.0686	CbGeAlD
Pimecrolimus—FKBP1A—bronchus—chronic obstructive pulmonary disease	0.00565	0.0642	CbGeAlD
Pimecrolimus—FKBP1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00553	0.0628	CbGeAlD
Pimecrolimus—FKBP1A—trachea—chronic obstructive pulmonary disease	0.00508	0.0576	CbGeAlD
Pimecrolimus—MTOR—lung—chronic obstructive pulmonary disease	0.00406	0.046	CbGeAlD
Pimecrolimus—FKBP1A—lung—chronic obstructive pulmonary disease	0.00365	0.0414	CbGeAlD
Pimecrolimus—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00261	CcSEcCtD
Pimecrolimus—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.000994	0.0026	CcSEcCtD
Pimecrolimus—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000994	0.0026	CcSEcCtD
Pimecrolimus—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000991	0.00259	CcSEcCtD
Pimecrolimus—Viral infection—Prednisolone—chronic obstructive pulmonary disease	0.000988	0.00258	CcSEcCtD
Pimecrolimus—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000976	0.00255	CcSEcCtD
Pimecrolimus—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000976	0.00255	CcSEcCtD
Pimecrolimus—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000974	0.00254	CcSEcCtD
Pimecrolimus—Herpes simplex—Prednisolone—chronic obstructive pulmonary disease	0.000968	0.00253	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000961	0.00251	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000961	0.00251	CcSEcCtD
Pimecrolimus—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000958	0.0025	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000947	0.00247	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000941	0.00246	CcSEcCtD
Pimecrolimus—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000939	0.00245	CcSEcCtD
Pimecrolimus—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000926	0.00242	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000924	0.00241	CcSEcCtD
Pimecrolimus—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00092	0.0024	CcSEcCtD
Pimecrolimus—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000916	0.00239	CcSEcCtD
Pimecrolimus—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000908	0.00237	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000907	0.00237	CcSEcCtD
Pimecrolimus—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000903	0.00236	CcSEcCtD
Pimecrolimus—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000903	0.00236	CcSEcCtD
Pimecrolimus—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000896	0.00234	CcSEcCtD
Pimecrolimus—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000896	0.00234	CcSEcCtD
Pimecrolimus—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000893	0.00233	CcSEcCtD
Pimecrolimus—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.000878	0.00229	CcSEcCtD
Pimecrolimus—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000865	0.00226	CcSEcCtD
Pimecrolimus—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000865	0.00226	CcSEcCtD
Pimecrolimus—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000863	0.00225	CcSEcCtD
Pimecrolimus—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000853	0.00223	CcSEcCtD
Pimecrolimus—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000852	0.00222	CcSEcCtD
Pimecrolimus—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000847	0.00221	CcSEcCtD
Pimecrolimus—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000846	0.00221	CcSEcCtD
Pimecrolimus—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00083	0.00217	CcSEcCtD
Pimecrolimus—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00083	0.00217	CcSEcCtD
Pimecrolimus—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000821	0.00214	CcSEcCtD
Pimecrolimus—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000821	0.00214	CcSEcCtD
Pimecrolimus—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000821	0.00214	CcSEcCtD
Pimecrolimus—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000817	0.00213	CcSEcCtD
Pimecrolimus—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000816	0.00213	CcSEcCtD
Pimecrolimus—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000813	0.00212	CcSEcCtD
Pimecrolimus—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000804	0.0021	CcSEcCtD
Pimecrolimus—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000793	0.00207	CcSEcCtD
Pimecrolimus—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000783	0.00205	CcSEcCtD
Pimecrolimus—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000779	0.00203	CcSEcCtD
Pimecrolimus—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000775	0.00202	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000772	0.00202	CcSEcCtD
Pimecrolimus—Acne—Prednisone—chronic obstructive pulmonary disease	0.000771	0.00201	CcSEcCtD
Pimecrolimus—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000767	0.002	CcSEcCtD
Pimecrolimus—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00076	0.00198	CcSEcCtD
Pimecrolimus—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000758	0.00198	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000755	0.00197	CcSEcCtD
Pimecrolimus—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000747	0.00195	CcSEcCtD
Pimecrolimus—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000747	0.00195	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000746	0.00195	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000746	0.00195	CcSEcCtD
Pimecrolimus—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000736	0.00192	CcSEcCtD
Pimecrolimus—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000732	0.00191	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00073	0.00191	CcSEcCtD
Pimecrolimus—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00073	0.00191	CcSEcCtD
Pimecrolimus—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00073	0.00191	CcSEcCtD
Pimecrolimus—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000728	0.0019	CcSEcCtD
Pimecrolimus—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000726	0.00189	CcSEcCtD
Pimecrolimus—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.00189	CcSEcCtD
Pimecrolimus—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000724	0.00189	CcSEcCtD
Pimecrolimus—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00072	0.00188	CcSEcCtD
Pimecrolimus—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00072	0.00188	CcSEcCtD
Pimecrolimus—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.000718	0.00187	CcSEcCtD
Pimecrolimus—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000714	0.00187	CcSEcCtD
Pimecrolimus—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000708	0.00185	CcSEcCtD
Pimecrolimus—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00184	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000704	0.00184	CcSEcCtD
Pimecrolimus—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00182	CcSEcCtD
Pimecrolimus—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00182	CcSEcCtD
Pimecrolimus—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000688	0.0018	CcSEcCtD
Pimecrolimus—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00068	0.00178	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000664	0.00173	CcSEcCtD
Pimecrolimus—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000658	0.00172	CcSEcCtD
Pimecrolimus—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000658	0.00172	CcSEcCtD
Pimecrolimus—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000658	0.00172	CcSEcCtD
Pimecrolimus—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000654	0.00171	CcSEcCtD
Pimecrolimus—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000645	0.00168	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000632	0.00165	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00164	CcSEcCtD
Pimecrolimus—Cough—Formoterol—chronic obstructive pulmonary disease	0.000629	0.00164	CcSEcCtD
Pimecrolimus—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000629	0.00164	CcSEcCtD
Pimecrolimus—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000623	0.00163	CcSEcCtD
Pimecrolimus—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00162	CcSEcCtD
Pimecrolimus—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000619	0.00162	CcSEcCtD
Pimecrolimus—Cough—Montelukast—chronic obstructive pulmonary disease	0.000616	0.00161	CcSEcCtD
Pimecrolimus—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000614	0.0016	CcSEcCtD
Pimecrolimus—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.0016	CcSEcCtD
Pimecrolimus—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000613	0.0016	CcSEcCtD
Pimecrolimus—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000611	0.00159	CcSEcCtD
Pimecrolimus—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000611	0.00159	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000609	0.00159	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000609	0.00159	CcSEcCtD
Pimecrolimus—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000601	0.00157	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000597	0.00156	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000596	0.00156	CcSEcCtD
Pimecrolimus—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000594	0.00155	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00153	CcSEcCtD
Pimecrolimus—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00153	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00153	CcSEcCtD
Pimecrolimus—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00153	CcSEcCtD
Pimecrolimus—Infection—Formoterol—chronic obstructive pulmonary disease	0.000584	0.00152	CcSEcCtD
Pimecrolimus—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000584	0.00152	CcSEcCtD
Pimecrolimus—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00151	CcSEcCtD
Pimecrolimus—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000579	0.00151	CcSEcCtD
Pimecrolimus—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000577	0.00151	CcSEcCtD
Pimecrolimus—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000577	0.00151	CcSEcCtD
Pimecrolimus—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000576	0.0015	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000576	0.0015	CcSEcCtD
Pimecrolimus—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000576	0.0015	CcSEcCtD
Pimecrolimus—Infection—Montelukast—chronic obstructive pulmonary disease	0.000572	0.00149	CcSEcCtD
Pimecrolimus—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000571	0.00149	CcSEcCtD
Pimecrolimus—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.00149	CcSEcCtD
Pimecrolimus—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000569	0.00149	CcSEcCtD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB3—chronic obstructive pulmonary disease	0.000566	0.00388	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000565	0.00147	CcSEcCtD
Pimecrolimus—MTOR—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000561	0.00385	CbGpPWpGaD
Pimecrolimus—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00056	0.00384	CbGpPWpGaD
Pimecrolimus—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000559	0.00146	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00145	CcSEcCtD
Pimecrolimus—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00145	CcSEcCtD
Pimecrolimus—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000551	0.00144	CcSEcCtD
Pimecrolimus—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000547	0.00143	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000545	0.00373	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.00142	CcSEcCtD
Pimecrolimus—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00141	CcSEcCtD
Pimecrolimus—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000537	0.0014	CcSEcCtD
Pimecrolimus—MTOR—Downstream signal transduction—KL—chronic obstructive pulmonary disease	0.000536	0.00368	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.0014	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000536	0.0014	CcSEcCtD
Pimecrolimus—MTOR—Signaling by FGFR—KL—chronic obstructive pulmonary disease	0.000533	0.00366	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—KL—chronic obstructive pulmonary disease	0.000531	0.00364	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000529	0.00138	CcSEcCtD
Pimecrolimus—MTOR—DAP12 signaling—KL—chronic obstructive pulmonary disease	0.000528	0.00362	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000525	0.00137	CcSEcCtD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000525	0.0036	CbGpPWpGaD
Pimecrolimus—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00137	CcSEcCtD
Pimecrolimus—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00137	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000522	0.00358	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KL—chronic obstructive pulmonary disease	0.00052	0.00357	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000517	0.00135	CcSEcCtD
Pimecrolimus—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00135	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000514	0.00352	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—PLAU—chronic obstructive pulmonary disease	0.000513	0.00352	CbGpPWpGaD
Pimecrolimus—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00133	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00133	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00132	CcSEcCtD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL1B—chronic obstructive pulmonary disease	0.000505	0.00346	CbGpPWpGaD
Pimecrolimus—Pain—Formoterol—chronic obstructive pulmonary disease	0.000503	0.00131	CcSEcCtD
Pimecrolimus—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.00131	CcSEcCtD
Pimecrolimus—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.00131	CcSEcCtD
Pimecrolimus—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000503	0.00131	CcSEcCtD
Pimecrolimus—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.0013	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000497	0.0013	CcSEcCtD
Pimecrolimus—MTOR—Signaling by FGFR in disease—KL—chronic obstructive pulmonary disease	0.000497	0.00341	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KL—chronic obstructive pulmonary disease	0.000497	0.00341	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—KL—chronic obstructive pulmonary disease	0.000497	0.00341	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.000496	0.0034	CbGpPWpGaD
Pimecrolimus—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00129	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000493	0.00338	CbGpPWpGaD
Pimecrolimus—Pain—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00129	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR—KL—chronic obstructive pulmonary disease	0.000492	0.00338	CbGpPWpGaD
Pimecrolimus—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000491	0.00128	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—KL—chronic obstructive pulmonary disease	0.000488	0.00335	CbGpPWpGaD
Pimecrolimus—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000487	0.00127	CcSEcCtD
Pimecrolimus—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000487	0.00127	CcSEcCtD
Pimecrolimus—MTOR—Signaling by PDGF—KL—chronic obstructive pulmonary disease	0.000486	0.00333	CbGpPWpGaD
Pimecrolimus—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000485	0.00127	CcSEcCtD
Pimecrolimus—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000484	0.00126	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00126	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00126	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00125	CcSEcCtD
Pimecrolimus—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00124	CcSEcCtD
Pimecrolimus—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00124	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000471	0.00123	CcSEcCtD
Pimecrolimus—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000467	0.00122	CcSEcCtD
Pimecrolimus—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000467	0.00122	CcSEcCtD
Pimecrolimus—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000465	0.00121	CcSEcCtD
Pimecrolimus—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000465	0.00121	CcSEcCtD
Pimecrolimus—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.00121	CcSEcCtD
Pimecrolimus—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.00121	CcSEcCtD
Pimecrolimus—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000463	0.00121	CcSEcCtD
Pimecrolimus—MTOR—B Cell Activation—KL—chronic obstructive pulmonary disease	0.00046	0.00315	CbGpPWpGaD
Pimecrolimus—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000459	0.0012	CcSEcCtD
Pimecrolimus—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000459	0.0012	CcSEcCtD
Pimecrolimus—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.0012	CcSEcCtD
Pimecrolimus—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000457	0.00119	CcSEcCtD
Pimecrolimus—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000456	0.00119	CcSEcCtD
Pimecrolimus—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000455	0.00119	CcSEcCtD
Pimecrolimus—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000455	0.00119	CcSEcCtD
Pimecrolimus—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000454	0.00119	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00119	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.000452	0.0031	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—ERBB3—chronic obstructive pulmonary disease	0.000447	0.00306	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000446	0.00306	CbGpPWpGaD
Pimecrolimus—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.00115	CcSEcCtD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KL—chronic obstructive pulmonary disease	0.00044	0.00302	CbGpPWpGaD
Pimecrolimus—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.00115	CcSEcCtD
Pimecrolimus—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.00115	CcSEcCtD
Pimecrolimus—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.00113	CcSEcCtD
Pimecrolimus—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000433	0.00113	CcSEcCtD
Pimecrolimus—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000433	0.00113	CcSEcCtD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—ERBB3—chronic obstructive pulmonary disease	0.000427	0.00293	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00111	CcSEcCtD
Pimecrolimus—MTOR—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000422	0.0029	CbGpPWpGaD
Pimecrolimus—MTOR—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000421	0.00289	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000421	0.00288	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—chronic obstructive pulmonary disease	0.00042	0.00288	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB Signaling Pathway—EGFR—chronic obstructive pulmonary disease	0.000418	0.00287	CbGpPWpGaD
Pimecrolimus—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00109	CcSEcCtD
Pimecrolimus—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00109	CcSEcCtD
Pimecrolimus—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000412	0.00282	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00107	CcSEcCtD
Pimecrolimus—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00106	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000406	0.00278	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00105	CcSEcCtD
Pimecrolimus—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00105	CcSEcCtD
Pimecrolimus—MTOR—Downstream signal transduction—ERBB3—chronic obstructive pulmonary disease	0.000402	0.00275	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—VEGFA—chronic obstructive pulmonary disease	0.000401	0.00275	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—ERBB3—chronic obstructive pulmonary disease	0.0004	0.00274	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000398	0.00273	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—ERBB3—chronic obstructive pulmonary disease	0.000398	0.00273	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—SERPINE1—chronic obstructive pulmonary disease	0.000397	0.00272	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—ERBB3—chronic obstructive pulmonary disease	0.000396	0.00271	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00103	CcSEcCtD
Pimecrolimus—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00103	CcSEcCtD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TNF—chronic obstructive pulmonary disease	0.000393	0.00269	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000391	0.00268	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—ERBB3—chronic obstructive pulmonary disease	0.00039	0.00268	CbGpPWpGaD
Pimecrolimus—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00039	0.00102	CcSEcCtD
Pimecrolimus—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.000992	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000379	0.0026	CbGpPWpGaD
Pimecrolimus—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000374	0.000976	CcSEcCtD
Pimecrolimus—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.000976	CcSEcCtD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—NOS3—chronic obstructive pulmonary disease	0.000373	0.00256	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—ERBB3—chronic obstructive pulmonary disease	0.000372	0.00255	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—ERBB3—chronic obstructive pulmonary disease	0.000372	0.00255	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—ERBB3—chronic obstructive pulmonary disease	0.000372	0.00255	CbGpPWpGaD
Pimecrolimus—Rash—Formoterol—chronic obstructive pulmonary disease	0.000371	0.000968	CcSEcCtD
Pimecrolimus—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.000968	CcSEcCtD
Pimecrolimus—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.000967	CcSEcCtD
Pimecrolimus—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00037	0.000967	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR—ERBB3—chronic obstructive pulmonary disease	0.000369	0.00253	CbGpPWpGaD
Pimecrolimus—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.000962	CcSEcCtD
Pimecrolimus—Headache—Formoterol—chronic obstructive pulmonary disease	0.000368	0.000962	CcSEcCtD
Pimecrolimus—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000366	0.000956	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—ERBB3—chronic obstructive pulmonary disease	0.000366	0.00251	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—ERBB3—chronic obstructive pulmonary disease	0.000364	0.0025	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—HDAC2—chronic obstructive pulmonary disease	0.000364	0.0025	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—MMP9—chronic obstructive pulmonary disease	0.000364	0.00249	CbGpPWpGaD
Pimecrolimus—Rash—Montelukast—chronic obstructive pulmonary disease	0.000363	0.000948	CcSEcCtD
Pimecrolimus—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000363	0.000947	CcSEcCtD
Pimecrolimus—Headache—Montelukast—chronic obstructive pulmonary disease	0.000361	0.000942	CcSEcCtD
Pimecrolimus—MTOR—TSLP Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000359	0.00246	CbGpPWpGaD
Pimecrolimus—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000356	0.000931	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	0.000355	0.00243	CbGpPWpGaD
Pimecrolimus—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.000921	CcSEcCtD
Pimecrolimus—MTOR—Signaling by VEGF—NOS3—chronic obstructive pulmonary disease	0.000352	0.00242	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB Signaling Pathway—TP53—chronic obstructive pulmonary disease	0.000351	0.00241	CbGpPWpGaD
Pimecrolimus—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.000914	CcSEcCtD
Pimecrolimus—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.000913	CcSEcCtD
Pimecrolimus—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.000912	CcSEcCtD
Pimecrolimus—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000349	0.000912	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	0.000348	0.00239	CbGpPWpGaD
Pimecrolimus—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.000908	CcSEcCtD
Pimecrolimus—MTOR—B Cell Activation—ERBB3—chronic obstructive pulmonary disease	0.000345	0.00236	CbGpPWpGaD
Pimecrolimus—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000342	0.000893	CcSEcCtD
Pimecrolimus—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000341	0.00234	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—KL—chronic obstructive pulmonary disease	0.000338	0.00232	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—chronic obstructive pulmonary disease	0.000336	0.00231	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000334	0.00229	CbGpPWpGaD
Pimecrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000333	0.00228	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB3—chronic obstructive pulmonary disease	0.00033	0.00226	CbGpPWpGaD
Pimecrolimus—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.000861	CcSEcCtD
Pimecrolimus—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000329	0.00225	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—chronic obstructive pulmonary disease	0.000323	0.00221	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.00032	0.0022	CbGpPWpGaD
Pimecrolimus—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.000831	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.000831	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000311	0.00213	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000306	0.0021	CbGpPWpGaD
Pimecrolimus—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000304	0.000795	CcSEcCtD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—chronic obstructive pulmonary disease	0.000303	0.00208	CbGpPWpGaD
Pimecrolimus—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000302	0.000789	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000301	0.00206	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—chronic obstructive pulmonary disease	0.0003	0.00205	CbGpPWpGaD
Pimecrolimus—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000299	0.00205	CbGpPWpGaD
Pimecrolimus—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000768	CcSEcCtD
Pimecrolimus—MTOR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000289	0.00198	CbGpPWpGaD
Pimecrolimus—MTOR—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000289	0.00198	CbGpPWpGaD
Pimecrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—EGFR—chronic obstructive pulmonary disease	0.000288	0.00198	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.000746	CcSEcCtD
Pimecrolimus—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000283	0.00074	CcSEcCtD
Pimecrolimus—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000283	0.00074	CcSEcCtD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—chronic obstructive pulmonary disease	0.00028	0.00192	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000276	0.00189	CbGpPWpGaD
Pimecrolimus—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.000711	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000271	0.00186	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000271	0.00186	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00027	0.00185	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—VEGFA—chronic obstructive pulmonary disease	0.000269	0.00184	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—NOS3—chronic obstructive pulmonary disease	0.000268	0.00184	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—LY96—chronic obstructive pulmonary disease	0.000263	0.00181	CbGpPWpGaD
Pimecrolimus—MTOR—PI-3K cascade—EGFR—chronic obstructive pulmonary disease	0.00026	0.00178	CbGpPWpGaD
Pimecrolimus—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000676	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000258	0.00177	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—VEGFA—chronic obstructive pulmonary disease	0.000254	0.00174	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	0.000254	0.00174	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—EGFR—chronic obstructive pulmonary disease	0.000254	0.00174	CbGpPWpGaD
Pimecrolimus—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00066	CcSEcCtD
Pimecrolimus—MTOR—GAB1 signalosome—EGFR—chronic obstructive pulmonary disease	0.000252	0.00173	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—chronic obstructive pulmonary disease	0.000251	0.00172	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB1 downstream signaling—EGFR—chronic obstructive pulmonary disease	0.000246	0.00169	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—chronic obstructive pulmonary disease	0.000246	0.00169	CbGpPWpGaD
Pimecrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000242	0.00166	CbGpPWpGaD
Pimecrolimus—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00063	CcSEcCtD
Pimecrolimus—MTOR—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	0.00024	0.00165	CbGpPWpGaD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000626	CcSEcCtD
Pimecrolimus—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.00164	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000236	0.00162	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000612	CcSEcCtD
Pimecrolimus—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000604	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000604	CcSEcCtD
Pimecrolimus—Infection—Prednisone—chronic obstructive pulmonary disease	0.00023	0.0006	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000227	0.00156	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000592	CcSEcCtD
Pimecrolimus—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000587	CcSEcCtD
Pimecrolimus—MTOR—IRS-mediated signalling—IL6—chronic obstructive pulmonary disease	0.000224	0.00153	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events—IL6—chronic obstructive pulmonary disease	0.000218	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—chronic obstructive pulmonary disease	0.000216	0.00148	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00055	CcSEcCtD
Pimecrolimus—MTOR—IGF1R signaling cascade—IL6—chronic obstructive pulmonary disease	0.00021	0.00144	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin receptor signalling cascade—IL6—chronic obstructive pulmonary disease	0.00021	0.00144	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000542	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	0.000206	0.00142	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000205	0.00141	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000204	0.0014	CbGpPWpGaD
Pimecrolimus—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000524	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000524	CcSEcCtD
Pimecrolimus—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.000521	CcSEcCtD
Pimecrolimus—FKBP1A—Disease—HDAC2—chronic obstructive pulmonary disease	0.000199	0.00136	CbGpPWpGaD
Pimecrolimus—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000517	CcSEcCtD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00135	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	0.000194	0.00133	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000193	0.00132	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00019	0.0013	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000494	CcSEcCtD
Pimecrolimus—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000494	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	0.000189	0.0013	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	0.000186	0.00128	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	0.000186	0.00127	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000185	0.00127	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—KL—chronic obstructive pulmonary disease	0.000185	0.00127	CbGpPWpGaD
Pimecrolimus—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00048	CcSEcCtD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000184	0.00126	CbGpPWpGaD
Pimecrolimus—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000478	CcSEcCtD
Pimecrolimus—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000478	CcSEcCtD
Pimecrolimus—MTOR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000183	0.00125	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	0.000176	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000175	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	0.000175	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	0.000174	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	0.000174	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	0.000174	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	0.000173	0.00119	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000173	0.00118	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	0.000172	0.00118	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000171	0.00117	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000445	CcSEcCtD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	0.00017	0.00116	CbGpPWpGaD
Pimecrolimus—Tacrolimus—ALB—chronic obstructive pulmonary disease	0.000169	1	CrCbGaD
Pimecrolimus—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000427	CcSEcCtD
Pimecrolimus—MTOR—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	0.000162	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	0.000162	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	0.000162	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000161	0.0011	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	0.00016	0.0011	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	0.000159	0.00109	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000413	CcSEcCtD
Pimecrolimus—MTOR—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	0.000158	0.00109	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000154	0.00106	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—EGFR—chronic obstructive pulmonary disease	0.00015	0.00103	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000149	0.00102	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	0.000149	0.00102	CbGpPWpGaD
Pimecrolimus—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000384	CcSEcCtD
Pimecrolimus—Rash—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000381	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000381	CcSEcCtD
Pimecrolimus—Headache—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000378	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000145	0.000992	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.000983	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	0.000143	0.000983	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	0.000143	0.000979	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00097	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	0.000141	0.000964	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000139	0.000953	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000139	0.000953	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—ERBB3—chronic obstructive pulmonary disease	0.000138	0.000949	CbGpPWpGaD
Pimecrolimus—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000359	CcSEcCtD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	0.000134	0.00092	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	0.000134	0.000916	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	0.000133	0.000911	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000133	0.00091	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000132	0.000907	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—chronic obstructive pulmonary disease	0.000132	0.000907	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.000131	0.000896	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000129	0.000886	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000127	0.00087	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	0.000124	0.000853	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	0.000124	0.000853	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—chronic obstructive pulmonary disease	0.000124	0.000853	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	0.000123	0.000845	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	0.000122	0.000838	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	0.000122	0.000834	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00012	0.00082	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR2—chronic obstructive pulmonary disease	0.00012	0.00082	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000119	0.000818	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000118	0.000809	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS2—chronic obstructive pulmonary disease	0.000115	0.000791	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—KL—chronic obstructive pulmonary disease	0.000112	0.000771	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HDAC2—chronic obstructive pulmonary disease	0.000112	0.000766	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	0.00011	0.000756	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	0.00011	0.000756	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00011	0.000754	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000108	0.000743	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000107	0.000733	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000107	0.000731	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.000715	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—KL—chronic obstructive pulmonary disease	0.000104	0.000712	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.000705	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	9.87e-05	0.000677	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SERPINE1—chronic obstructive pulmonary disease	9.71e-05	0.000666	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.69e-05	0.000664	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.32e-05	0.000639	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS3—chronic obstructive pulmonary disease	9.27e-05	0.000636	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD8A—chronic obstructive pulmonary disease	9.06e-05	0.000621	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	9.03e-05	0.00062	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.67e-05	0.000594	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—chronic obstructive pulmonary disease	8.47e-05	0.000581	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ERBB3—chronic obstructive pulmonary disease	8.43e-05	0.000578	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	8.38e-05	0.000575	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.82e-05	0.000536	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ERBB3—chronic obstructive pulmonary disease	7.78e-05	0.000534	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—chronic obstructive pulmonary disease	7.71e-05	0.000528	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR4—chronic obstructive pulmonary disease	7.39e-05	0.000507	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.27e-05	0.000498	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.8e-05	0.000466	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.71e-05	0.00046	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.49e-05	0.000445	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS2—chronic obstructive pulmonary disease	6.49e-05	0.000445	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.29e-05	0.000431	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—chronic obstructive pulmonary disease	6.13e-05	0.000421	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.04e-05	0.000414	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—EGFR—chronic obstructive pulmonary disease	6.01e-05	0.000412	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.99e-05	0.000411	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.76e-05	0.000395	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.55e-05	0.000381	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SERPINE1—chronic obstructive pulmonary disease	5.46e-05	0.000375	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.45e-05	0.000374	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.4e-05	0.00037	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.24e-05	0.00036	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS3—chronic obstructive pulmonary disease	5.22e-05	0.000358	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.21e-05	0.000357	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.02e-05	0.000344	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.88e-05	0.000334	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.83e-05	0.000331	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—chronic obstructive pulmonary disease	4.81e-05	0.00033	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.68e-05	0.000321	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—chronic obstructive pulmonary disease	4.62e-05	0.000317	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.29e-05	0.000295	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.21e-05	0.000289	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.83e-05	0.000262	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.000251	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.65e-05	0.00025	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.54e-05	0.000242	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—chronic obstructive pulmonary disease	3.45e-05	0.000237	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—EGFR—chronic obstructive pulmonary disease	3.38e-05	0.000232	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.24e-05	0.000222	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.24e-05	0.000222	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.95e-05	0.000202	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.93e-05	0.000201	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.92e-05	0.0002	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—chronic obstructive pulmonary disease	2.81e-05	0.000193	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.66e-05	0.000183	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.63e-05	0.00018	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000178	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.000168	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.42e-05	0.000166	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.37e-05	0.000162	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.00014	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.02e-05	0.000138	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.99e-05	0.000136	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.000129	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.82e-05	0.000125	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.000122	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-05	8.31e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	7.95e-05	CbGpPWpGaD
